APA (7th ed.) Citation

A, M., B, B., L, R., G, H., N, P., F, M., . . . M, S. (2023). CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells. Cancer immunology, immunotherapy : CII, 72(7), 2499. https://doi.org/10.1007/s00262-023-03439-x

Chicago Style (17th ed.) Citation

A, Marcinek, et al. "CD33 BiTE® Molecule-mediated Immune Synapse Formation and Subsequent T-cell Activation Is Determined by the Expression Profile of Activating and Inhibitory Checkpoint Molecules on AML Cells." Cancer Immunology, Immunotherapy : CII 72, no. 7 (2023): 2499. https://doi.org/10.1007/s00262-023-03439-x.

MLA (9th ed.) Citation

A, Marcinek, et al. "CD33 BiTE® Molecule-mediated Immune Synapse Formation and Subsequent T-cell Activation Is Determined by the Expression Profile of Activating and Inhibitory Checkpoint Molecules on AML Cells." Cancer Immunology, Immunotherapy : CII, vol. 72, no. 7, 2023, p. 2499, https://doi.org/10.1007/s00262-023-03439-x.